PURPOSE: In this study, we investigated the effect of a slow-releasing hydrogen sulfide (H2S) donor, GYY 4137, on intraocular pressure (IOP) in normotensive rabbits. Furthermore, we compared the IOP-lowering action of GYY 4137 with those elicited by other H2S-producing compounds, l-cysteine and ACS67 (a hybrid compound of latanoprost with an H2S-releasing moiety). METHODS: IOP was measured in New Zealand normotensive male albino rabbits using a pneumatonometer (model 30 classic; Reichert Ophthalmic Instruments, Depew, NY). At 0 h, 50 μL of test compounds were applied topically to 1 eye of each animal, while the contralateral eye received the same quantity of vehicle (saline). IOP was measured hourly until baseline IOP readings were attained and animal eyes monitored for potential side effects (i.e., tearing, hyperemia). RESULTS: GYY 4137 (0.1%-2%) produced a dose-dependent decrease in IOP reaching a maximum of 27.8% ± 3.14% (n = 5) after 6 h. Interestingly, a significant contralateral effect was observed in vehicle-treated controls eyes at all doses tested. l-cysteine (5%) and ACS67 (0.005%) also elicited a significant (P < 0.01) decrease in IOP that achieved a maximum of 28.84% ± 1.53% (n = 5) and 23.27% ± 0.51% (n = 5), respectively, after 3 h. All 3 H2S-producing compounds also caused a significant contralateral effect in vehicle-treated control eyes. CONCLUSION: We conclude that GYY 4137 and other H2S-producing donors can reduce IOP in normotensive rabbits. However, the profile of IOP-lowering action of GYY 4137 was different from the other H2S donors affirming its ability to act as a slow-releasing gas donor.
PURPOSE: In this study, we investigated the effect of a slow-releasing hydrogen sulfide (H2S) donor, GYY 4137, on intraocular pressure (IOP) in normotensive rabbits. Furthermore, we compared the IOP-lowering action of GYY 4137 with those elicited by other H2S-producing compounds, l-cysteine and ACS67 (a hybrid compound of latanoprost with an H2S-releasing moiety). METHODS: IOP was measured in New Zealand normotensive male albino rabbits using a pneumatonometer (model 30 classic; Reichert Ophthalmic Instruments, Depew, NY). At 0 h, 50 μL of test compounds were applied topically to 1 eye of each animal, while the contralateral eye received the same quantity of vehicle (saline). IOP was measured hourly until baseline IOP readings were attained and animal eyes monitored for potential side effects (i.e., tearing, hyperemia). RESULTS:GYY 4137 (0.1%-2%) produced a dose-dependent decrease in IOP reaching a maximum of 27.8% ± 3.14% (n = 5) after 6 h. Interestingly, a significant contralateral effect was observed in vehicle-treated controls eyes at all doses tested. l-cysteine (5%) and ACS67 (0.005%) also elicited a significant (P < 0.01) decrease in IOP that achieved a maximum of 28.84% ± 1.53% (n = 5) and 23.27% ± 0.51% (n = 5), respectively, after 3 h. All 3 H2S-producing compounds also caused a significant contralateral effect in vehicle-treated control eyes. CONCLUSION: We conclude that GYY 4137 and other H2S-producing donors can reduce IOP in normotensive rabbits. However, the profile of IOP-lowering action of GYY 4137 was different from the other H2S donors affirming its ability to act as a slow-releasing gas donor.
Authors: Madhura Kulkarni; Ya Fatou Njie-Mbye; Ikechukwu Okpobiri; Min Zhao; Catherine A Opere; Sunny E Ohia Journal: Neurochem Res Date: 2011-05-01 Impact factor: 3.996
Authors: Elena Perrino; Caterina Uliva; Cecilia Lanzi; Piero Del Soldato; Emanuela Masini; Anna Sparatore Journal: Bioorg Med Chem Lett Date: 2009-02-08 Impact factor: 2.823
Authors: Johannes B Roedl; Stefan Bleich; Udo Reulbach; Robert Rejdak; Johannes Kornhuber; Friedrich E Kruse; Ursula Schlötzer-Schrehardt; Anselm G Jünemann Journal: J Glaucoma Date: 2007-03 Impact factor: 2.503
Authors: Neville N Osborne; Dan Ji; Aman S Abdul Majid; Rebecca J Fawcett; Anna Sparatore; Piero Del Soldato Journal: Invest Ophthalmol Vis Sci Date: 2009-08-26 Impact factor: 4.799
Authors: Praveen K Balne; Nishant R Sinha; Alexandria C Hofmann; Lynn M Martin; Rajiv R Mohan Journal: Ann N Y Acad Sci Date: 2020-09-20 Impact factor: 6.499
Authors: Stefan Muenster; Wolfgang S Lieb; Gregor Fabry; Kaitlin N Allen; Shivani S Kamat; Ann H Guy; Ana C Dordea; Leandro Teixeira; Robert E Tainsh; Binglan Yu; Wei Zhu; Nicole E Ashpole; Rajeev Malhotra; Peter Brouckaert; Donald B Bloch; Marielle Scherrer-Crosbie; W Daniel Stamer; Markus H Kuehn; Louis R Pasquale; Emmanuel S Buys Journal: Invest Ophthalmol Vis Sci Date: 2017-09-01 Impact factor: 4.799